EUVIMEDEUVIMED entdecken
Crossref

Clinical Efficiency of Medilac-Vita in Children with Neonatal Jaundice

立明 张

Asian Case Reports in Pediatrics · 2013

DOI: 10.12677/acrp.2013.13011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Case Reports in Pediatrics, 2013. Verfasst von 立明 张. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

目的:观察分析妈咪爱在新生儿黄疸治疗中的临床疗效。方法:112例新生儿黄疸患儿随机分为治疗组和对照组,每组56例。两组都给予常规治疗,治疗组在常规治疗基础上加服妈咪爱,并通过动态检测经皮测胆红素观察其临床疗效。结果:治疗组患儿血清胆红素与对照组比较下降明显(P < 0.01),且治疗组治疗7天后的有效率及治愈率方面明显优于对照组。结论:妈咪爱治疗新生儿黄疸,可迅速降低血清胆红素的水平,优于常规治疗。 Objective: To observe the clinical efficiency of Medilac-Vita in children with neonatal jaundice.

Methods

112 cases of newborn with neonatal jaundice were randomly divided into treatment group and control group. All were treated with routine therapy. Oral Medilac-Vita was added to the treatment group. Clinical efficiency was observed by detection of transcautaneous bilirubin.

Results

The level of transcautaneous bilirubin in treatment group was significantly lower than the control group. After 7 days of treatment, the effective rate and cure rate of the treatment group are obviously better than the control group.

Conclusions

Moreover, the effect of Medilac-Vita in treatment of neonatal jaundice is better than routine treatment, it can reduce the serum bilirubin rapidly.

Zitieren

APA

张, 立. (2013). Clinical Efficiency of Medilac-Vita in Children with Neonatal Jaundice. Asian Case Reports in Pediatrics. https://doi.org/10.12677/acrp.2013.13011

Vancouver

张 立. Clinical Efficiency of Medilac-Vita in Children with Neonatal Jaundice. Asian Case Reports in Pediatrics. 2013. doi:10.12677/acrp.2013.13011

BibTeX
@article{2013,
  author = {张, 立明},
  title = {Clinical Efficiency of Medilac-Vita in Children with Neonatal Jaundice},
  journal = {Asian Case Reports in Pediatrics},
  year = {2013},
  doi = {10.12677/acrp.2013.13011}
}
Kostenlos starten →